MTHFR and hyperhomocysteinemia: Genetic variants of the MTHFR gene, notably C677T and A1298C, can impair enzyme function, leading to hyperhomocysteinemia, a known prothrombotic and atherogenic factor associated with increased cardiovascular risk [8,9].